{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:30:36Z","timestamp":1772818236076,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.clinthera.2016.04.035","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T15:17:33Z","timestamp":1464103053000},"page":"1510-1521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pathogen Prevalence and Antimicrobial Susceptibility Among Enterobacteriaceae Causing Hospital-associated Intra-abdominal Infections in Adults in the United States (2012\u20132013)"],"prefix":"10.1016","volume":"38","author":[{"given":"Magdalena","family":"Zalacain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas J.","family":"Biedenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Badal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Motyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel F.","family":"Sahm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2016.04.035_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/joc.2009.21.Supplement-1.3","article-title":"Definition and classification of intra-abdominal infections","volume":"21","author":"Menichetti","year":"2009","journal-title":"J Chemother"},{"key":"10.1016\/j.clinthera.2016.04.035_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1749-7922-9-37","article-title":"Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study","volume":"9","author":"Sartelli","year":"2014","journal-title":"World J Emerg Surg"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2016.04.035_bib3","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1086\/519472","article-title":"Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical data","volume":"45","author":"Deresinski","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2016.04.035_bib4","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.amjmed.2006.03.034","article-title":"Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay","volume":"119","author":"Fraser","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2016.04.035_bib5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/513766","article-title":"Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals","volume":"25","author":"Shlaes","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2016.04.035_bib6","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.amjmed.2006.03.013","article-title":"Resistance in gram-negative bacteria: Enterobacteriaceae","volume":"119","author":"Paterson","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2016.04.035_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"50","author":"Solomkin","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2016.04.035_bib8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jhin.2009.02.021","article-title":"Extended-spectrum beta-lactamase-producing organisms","volume":"73","author":"Falagas","year":"2009","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.clinthera.2016.04.035_bib9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.diagmicrobio.2009.06.009","article-title":"Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007","volume":"66","author":"Hoban","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2016.04.035_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/sur.2009.057","article-title":"Epidemiologic trends, occurrence of extended-spectrum beta-lactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: analysis of global trend data from 2002-2007 from the SMART study","volume":"11","author":"Hawser","year":"2010","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.clinthera.2016.04.035_bib11","first-page":"625170","article-title":"ESBLs: a clear and present danger?","author":"Dhillon","year":"2012","journal-title":"Crit Care Res Pract"},{"key":"10.1016\/j.clinthera.2016.04.035_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10156-010-0120-2","article-title":"Plasmid-mediated quinolone resistance: an update","volume":"17","author":"Rodriguez-Martinez","year":"2011","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.clinthera.2016.04.035_bib13","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 9th ed. Approved standard M07-A9","year":"2012"},{"key":"10.1016\/j.clinthera.2016.04.035_bib14","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twenty-third Informational Supplement, in M100-S24","year":"2014"},{"key":"10.1016\/j.clinthera.2016.04.035_bib15","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/AAC.01808-09","article-title":"Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"54","author":"Hoban","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2016.04.035_bib16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.diagmicrobio.2014.03.026","article-title":"In vitro susceptibility and distribution of beta-lactamases in Enterobacteriaceae causing intra-abdominal infections in North America 2010-2011","volume":"9","author":"Hoban","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2016.04.035_bib17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.diagmicrobio.2013.02.031","article-title":"Trends in susceptibility of selected gram-negative bacilli isolated from intra-abdominal infections in North America: SMART 2005-2010","volume":"76","author":"Babinchak","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2016.04.035_bib18","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3390\/ph6111335","article-title":"A review of ten years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011","volume":"6","author":"Morrissey","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.clinthera.2016.04.035_bib19","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1128\/AAC.00070-11","article-title":"Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates","volume":"55","author":"Hawser","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2016.04.035_bib20","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.45.4.1151-1161.2001","article-title":"Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae","volume":"45","author":"Yigit","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2016.04.035_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/SMJ.0b013e3181fd7d5a","article-title":"Emergence of Klebsiella pneumoniae carbapenemase-producing bacteria","volume":"104","author":"Arnold","year":"2011","journal-title":"South Med J"},{"key":"10.1016\/j.clinthera.2016.04.035_bib22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1128\/AAC.00852-08","article-title":"Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type extended-spectrum beta-lactamases","volume":"53","author":"Ma","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2016.04.035_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1309\/LMDQQW246NYAHHAD","article-title":"High rate of aminoglycoside resistance in CTX-M-15 producing Klebsiella pneumoniae isolates in Tehran, Iran","volume":"45","author":"Peerayeh","year":"2014","journal-title":"Lab Med"},{"key":"10.1016\/j.clinthera.2016.04.035_bib24","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1128\/AAC.02684-13","article-title":"Variation in potency and spectrum of tigecycline activity against bacterial strains from U.S. medical centers since its approval for clinical use (2006 to 2012)","volume":"58","author":"Sader","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2016.04.035_bib25","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1128\/AAC.00576-07","article-title":"First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system","volume":"51","author":"Lewis","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2016.04.035_bib26","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1128\/AAC.00426-09","article-title":"Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007","volume":"53","author":"Hawser","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2016.04.035_bib27","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement, in M100-S20","year":"2010"},{"key":"10.1016\/j.clinthera.2016.04.035_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1155\/2014\/265981","article-title":"Effects of breakpoint changes on carbapenem susceptibility rates of Enterobacteriaceae: results from the SENTRY Antimicrobial Surveillance Program, United States, 2008 to 2012","volume":"25","author":"Rennie","year":"2014","journal-title":"Can J Infect Dis Med Microbiol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816302697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816302697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T19:17:48Z","timestamp":1567970268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291816302697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0149291816302697"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.04.035","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogen Prevalence and Antimicrobial Susceptibility Among Enterobacteriaceae Causing Hospital-associated Intra-abdominal Infections in Adults in the United States (2012\u20132013)","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}